The Meeting Point for Clinicians and Researchers to Share Knowledge on EoE


On Cover

New elected EUREOS Steering Committee 2017-2019

Thursday 15 March 2018

Dear EUREOS member, As the new EUREOS president I am delighted to provide you with an news update of our society. We are happy to welcome over 30 new members since our general assembly at UEGW2017 in October, a larger and more active network will improve our influence and capabilities… Read More


Invitation to the EUREOS General Assembly 2018 and EoE Clinical Trial Symposium

Sunday 22 July 2018

DEAR EUREOS MEMBER, As president of EUREOS I’m delighted to invite you to the General Assembly 2018, taking place on October 21st, in Vienna. We have decided to host our annual meeting this year in a hotel in central Vienna. The General Assembly will not only give you the opportunity… Read More

EUREOS and AEDESEO agree to collaborate to reach all patients with EoE

Sunday 10 June 2018

A collaboration agreement has been recently signed between EUREOS, the European Society of Eosinophilic Esophagitis, and AEDESEO, the Spanish Asociation of Patients with EoE, to promote knowledge about this disease among patients affected, their families and caregivers throughout Europe. The agreement also pursues the development and sharing of educational resources… Read More

Update on dysphagia and EoE

Saturday 30 December 2017

17-19-010 A5 Uitnodiging 24-01-18_A_HR Title: Update on dysphagia and EoE Location: Rosarium, Amstelpark 1. Amsterdam Start buffet 18.30, start first lecture 19.00 Chairs: Stephen Attwood and Arjan Bredenoord Prof dr André Smout Approach to a patient with dysphagia Prof dr Stephen Attwood How I discovered EoE Drs Marijn Warners EoE:… Read More

Jorveza approved under accelerated assessment

Saturday 18 November 2017

New medicine for Eosinophilic Esophagitis, a rare inflammatory condition of the oesophagus A press release available on the European Medicines Agency’s  website www.ema.europa.eu recommends granting a marketing authorisation in the European Union (EU) for Jorveza, a novel budesonide formula to treat EoE, after an application by Dr. Falk Pharma GmbH…. Read More